I totally believe the trials will be good. This company is probably way ahead than most stem cell companies. They are also doing great things regarding anti aging. Either way even if the results are stellar and the stock shoots up it will still be insanely over priced based on valuation. ie P/E, P/B, P/S, and EBITD